Healios KK (HLOSF)
0.9929
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Healios Cash from Investing (TTM): -7.990M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -7.990M |
September 30, 2023 | -8.232M |
June 30, 2023 | -4.761M |
March 31, 2023 | -8.252M |
December 31, 2022 | -6.971M |
September 30, 2022 | -7.576M |
June 30, 2022 | -8.060M |
March 31, 2022 | -6.062M |
December 31, 2021 | -6.708M |
Date | Value |
---|---|
September 30, 2021 | -5.761M |
June 30, 2021 | -6.124M |
March 31, 2021 | -13.53M |
December 31, 2020 | -11.39M |
September 30, 2020 | -9.962M |
June 30, 2020 | -9.292M |
March 31, 2020 | -1.057M |
December 31, 2019 | -0.2936M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-13.53M
Minimum
Mar 2021
-0.2936M
Maximum
Dec 2019
-7.178M
Average
-7.576M
Median
Sep 2022
Cash from Investing (TTM) Benchmarks
Takeda Pharmaceutical Co Ltd | -6.025B |
Nxera Pharma Co Ltd | -454.67M |
PeptiDream Inc | 9.284M |
Stemcell Holdings Inc | -1.163M |
AnGes Inc | -- |